Pegvaliase for the treatment of phenylketonuria: Results of the phase 2 dose-finding studies with long-term follow-up.

Burton BK, Longo N, Vockley J, Grange DK, Harding CO, Decker C, Li M, Lau K, Rosen O, Larimore K, Thomas J, PAL-002 and PAL-004 Investigators.

Open source

DOI
10.1016/j.ymgme.2020.06.006
Published
2020-06-16
Container
Mol Genet Metab
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.ymgme.2020.06.006,
  title = {Pegvaliase for the treatment of phenylketonuria: Results of the phase 2 dose-finding studies with long-term follow-up.},
  author = {Burton BK and  Longo N and  Vockley J and  Grange DK and  Harding CO and  Decker C and  Li M and  Lau K and  Rosen O and  Larimore K and  Thomas J and  PAL-002 and PAL-004 Investigators.},
  year = {2020},
  journal = {Mol Genet Metab},
  doi = {10.1016/j.ymgme.2020.06.006},
  url = {https://doi.org/10.1016/j.ymgme.2020.06.006}
}

RIS

TY  - JOUR
TI  - Pegvaliase for the treatment of phenylketonuria: Results of the phase 2 dose-finding studies with long-term follow-up.
AU  - Burton BK
AU  -  Longo N
AU  -  Vockley J
AU  -  Grange DK
AU  -  Harding CO
AU  -  Decker C
AU  -  Li M
AU  -  Lau K
AU  -  Rosen O
AU  -  Larimore K
AU  -  Thomas J
AU  -  PAL-002 and PAL-004 Investigators.
PY  - 2020
JO  - Mol Genet Metab
DO  - 10.1016/j.ymgme.2020.06.006
UR  - https://doi.org/10.1016/j.ymgme.2020.06.006
ER  - 

APA

BK, B., N, L., J, V., DK, G., CO, H., C, D., M, L., K, L., O, R., K, L., J, T., & Investigators., P. A. P. (2020). Pegvaliase for the treatment of phenylketonuria: Results of the phase 2 dose-finding studies with long-term follow-up.. Mol Genet Metab. https://doi.org/10.1016/j.ymgme.2020.06.006

Source records